It was reported that the procedure was performed to treat a de novo lesion with heavy tortuosity and 70% stenosis in the right vertebral artery.A 4.0 x 18mm herculink elite stent deliver system (sds) was being advanced; however, after the non-abbott guidewire crossed the vertebral artery, the sds failed to advance to the target lesion due to anatomy.Therefore, a 2.5mm balloon was used to dilate the lesion but the sds still failed to advance.The sds was withdrawn but also met resistance with anatomy and the stent dislodged.A snare was used to successfully retrieve the dislodged stent.The procedure ended at this point.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|
Visual analysis was performed on the returned product.The reported failure to advance and difficulty removing from the anatomy was not tested as it was based on procedural circumstances.The stent dislodgment was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other complaints reported from this lot.The investigation determined that the reported difficulties and subsequent treatment to remove the dislodged stent were due to case circumstances.It is likely that anatomical conditions contributed to the reported failure to cross, difficulty removing and stent dislodgment.It is likely that the stent became compromised on the balloon during the failed attempt to advance resulting in resistance and dislodgment during removal.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|